Clinical trials: Re-irradiation
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer
Radiotherapy in combination with different forms of immune therapy improved consistently local tumor control and very interestingly, lead to better systemic tumor control and the induction of specific anti-cancer immunity with a…
- Trial name
- NCT03406468
- Testing
- Radiotherapy
- Where
- 3 sites in Netherlands
- Volunteers
- 36 people
- Sponsor
- Maastricht Radiation Oncology
Squamous Cell Cancer of the Head and Neck
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
The standard treatment for head and neck cancer relapses in previously irradiated patients is controversial. Reirradiation has had some success, but many patients still die from their disease.
- Trial name
- NCT00934518
- Testing
- Radiation, Cetuximab
- Where
- United States
- Sponsor
- Milton S. Hershey Medical Center
Pediatric Malignant Brain Tumor -Diffuse Intrinsic Pontine Glioma
Palliative Re-irradiation for Progressive Diffuse Intrinsic Pontine Glioma (DIPG) in Children
Although DIPG is not curable, re-irradiation with a modest total dose and short treatment time provides good palliation of symptoms, improves quality of life, delays disease progression and has minimal and manageable toxicity.
- Trial name
- NCT01777633
- Testing
- Palliative re-irradiation for progressive DIPG in children
- Where
- Israel
- Volunteers
- 15 people
- Sponsor
- Hadassah Medical Organization
Head and Neck Cancer
Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy following surgery in treating patients who have recurrent or second primary…
- Trial name
- NCT00004226
- Testing
- radiation therapy
- Where
- 3 sites in United States
- Sponsor
- University of Alabama at Birmingham
Breast Cancer, Tumor, Breast
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
The standard treatment for participants whose cancer has returned after breast conserving surgery is radiation given twice daily (separated by at least 6 hours) for a total of 30 treatments.
- Trial name
- NCT06129747
- Testing
- Radiation Therapy
- Where
- 2 sites in United States
- Volunteers
- 55 people
- Sponsor
- Case Comprehensive Cancer Center